{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:51:39Z","timestamp":1786719099448,"version":"build-2736575974"},"reference-count":144,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/0028-3886.226441","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T06:59:49Z","timestamp":1521788389000},"page":"79","source":"Crossref","is-referenced-by-count":16,"title":["Botulinum toxin in movement disorders"],"prefix":"10.4103","volume":"66","author":[{"given":"Sanjay","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Tater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.226441-1","first-page":"455","volume-title":"Botulinum toxins: Pharmacology and its current therapeutic evidence for use","author":"Panicker","year":"2003","journal-title":"Neurol India","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3886","issn-type":"print"},{"key":"key-10.4103\/0028-3886.226441-2","doi-asserted-by":"crossref","unstructured":"Erbguth FJ, Naumann M. Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the \u201csausage poison.\u201d Neurology 1999;53:1850-3.","DOI":"10.1212\/WNL.53.8.1850"},{"key":"key-10.4103\/0028-3886.226441-3","first-page":"43","volume-title":"On the discovery of Clostridium botulinum","author":"Devriese","year":"1999","journal-title":"J Hist Neurosci"},{"key":"key-10.4103\/0028-3886.226441-4","first-page":"1044","volume-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0028-3886.226441-5","first-page":"394","volume-title":"History of botulinum toxin treatment in movement disorders","author":"Jabbari","year":"2016","journal-title":"Tremor Hyperkinetic Mov N Y N"},{"key":"key-10.4103\/0028-3886.226441-6","first-page":"624","volume-title":"Use of botulinum toxin in the neurology clinic","author":"Lim","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"key-10.4103\/0028-3886.226441-7","first-page":"399","volume-title":"Botulinum toxin for the treatment of movement disorders","author":"Thenganatt","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key-10.4103\/0028-3886.226441-8","first-page":"541","volume-title":"The occurrence of bacillus botulinus in nature","author":"Burke","year":"1919","journal-title":"J Bacteriol"},{"key":"key-10.4103\/0028-3886.226441-9","doi-asserted-by":"crossref","unstructured":"Truong D, Dressler D, Hallet M, Zachary C. Manual of Botulinum Toxin Therapy. Cambridge, UK, Cambride University Press, 2nd Edition. 2013.","DOI":"10.1017\/CBO9781139178068"},{"key":"key-10.4103\/0028-3886.226441-10","doi-asserted-by":"crossref","unstructured":"Scaglione F. Conversion ratio between Botox\u00ae, Dysport\u00ae, and Xeomin\u00ae in clinical practice. Toxins (Basel). 2016;8 (3). pii: E65. doi: 10.3390\/toxins8030065.","DOI":"10.3390\/toxins8030065"},{"key":"key-10.4103\/0028-3886.226441-11","first-page":"325","volume-title":"Clinical applications of botulinum toxin","author":"Dressler","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"key-10.4103\/0028-3886.226441-12","first-page":"628","volume-title":"Botulinum toxins in neurological disease","author":"Comella","year":"2004","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.226441-13","unstructured":"Lim EC-H, Seet RCS. Botulinum toxin: Description of injection techniques and examination of controversies surrounding toxin diffusion. Acta Neurol Scand 2008;117:73-84."},{"key":"key-10.4103\/0028-3886.226441-14","unstructured":"Hallett M. Mechanism of action of botulinum neurotoxin: Unexpected consequences. Toxicon. 2017 Aug 11. DOI: 10.1016\/j.toxicon. 2017.08.011."},{"key":"key-10.4103\/0028-3886.226441-15","first-page":"77","volume-title":"Clinical differences between botulinum neurotoxin type A and B.Toxicon Off J Int Soc Toxinology","author":"Bentivoglio","year":"2015","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-16","first-page":"21","volume-title":"Botulinum toxin in blepharospasm and oromandibular dystonia: Comparing different botulinum toxin preparations","author":"Bhidayasiri","year":"2006","journal-title":"Eur J Neurol"},{"key":"key-10.4103\/0028-3886.226441-17","first-page":"923","volume-title":"Ultrasound-guided botulinum toxin injections in neurology: Technique, indications and future perspectives","author":"Walter","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"key-10.4103\/0028-3886.226441-18","first-page":"889","volume-title":"Ultrasound-guided injection of the iliopsoas muscle with botulinum toxin in camptocormia.Mov Disord","author":"Von","year":"2008","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-19","first-page":"39","volume-title":"Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity.A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques?","author":"Santamato","year":"2014","journal-title":"J Neurol Sci"},{"key":"key-10.4103\/0028-3886.226441-20","first-page":"450","volume-title":"Accuracy of botulinum toxin type A injection into the gastrocnemius muscle of adults with spastic equinus: Manual needle placement and electrical stimulation guidance compared using ultrasonography.J Rehabil Med","author":"Picelli","year":"202;","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-21","first-page":"996","volume-title":"Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia","author":"Lee","year":"2009","journal-title":"Am J Roentgenol"},{"key":"key-10.4103\/0028-3886.226441-22","first-page":"e79","volume-title":"Impact of injection-guiding techniques on the effectiveness of botulinum toxin for the treatment of focal spasticity and dystonia: A systematic review","author":"Grigoriu","year":"2015","journal-title":"Ann PhysRehabil Med"},{"key":"key-10.4103\/0028-3886.226441-23","first-page":"531","volume-title":"Manual needle placement: Accuracy of botulinum toxin A injections","author":"Schnitzler","year":"2012","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.226441-24","first-page":"161","volume-title":"Uses of botulinum toxin injection in medicine today.BMJ","author":"M\u00fcnchau","year":"2000","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-25","first-page":"131","volume-title":"Blepharospasm and hemifacial spasm: Long-term treatment with botulinum toxin","author":"Gil","year":"2013","journal-title":"Neurol Barc Spain"},{"key":"key-10.4103\/0028-3886.226441-26","first-page":"255","volume-title":"Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm","author":"Price","year":"1994","journal-title":"Aust N Z J Ophthalmol"},{"key":"key-10.4103\/0028-3886.226441-27","doi-asserted-by":"crossref","unstructured":"Jost WH, Kohl A. Botulinum toxin: Evidence-based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 2001;248:I21-4.","DOI":"10.1007\/PL00007813"},{"key":"key-10.4103\/0028-3886.226441-28","first-page":"616","volume-title":"Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study.Neurology","author":"Jankovic","year":"1987","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-29","first-page":"84","volume-title":"Botulinum toxin treatment of blepharospasm, orofacial\/oromandibular dystonia, and hemifacial spasm","author":"Karp","year":"2016","journal-title":"Semin Neurol"},{"key":"key-10.4103\/0028-3886.226441-30","first-page":"344","volume-title":"Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: A 20-year follow-up","author":"Ramirez-Castaneda","year":"2014","journal-title":"Toxicon"},{"key":"key-10.4103\/0028-3886.226441-31","first-page":"427","volume-title":"Blepharospasm: Long-term treatment with either Botox\u00ae, Xeomin\u00ae or Dysport\u00ae","author":"Kollewe","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"key-10.4103\/0028-3886.226441-32","first-page":"238","volume-title":"Observational study of incobotulinumtoxina for cervical dystonia or blepharospasm (XCiDaBLE): Interim results for the first 170 subjects with blepharospasm","author":"Fernandez","year":"2014","journal-title":"Tremor Hyperkinetic Mov (N Y)"},{"key":"key-10.4103\/0028-3886.226441-33","first-page":"631","volume-title":"Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm.Can J Neurol Sci","author":"Gill","year":"2010","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-34","first-page":"345","volume-title":"Bilateral hemifacial spasm: A report of five cases and a literature review","author":"Tan","year":"1999","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-35","first-page":"154","volume-title":"Bilateral hemifacial spasm: A series of 10 patients with literature review","author":"Fel\u00edcio","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.4103\/0028-3886.226441-36","first-page":"1045","volume-title":"Treatment of hemifacial spasm with botulinum toxin","author":"Yoshimura","year":"1992","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.226441-37","first-page":"1319","volume-title":"Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.J Clin Neurosci","author":"Sorgun","year":"2015","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-38","first-page":"765","volume-title":"Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy.J Neural Transm (Vienna)","author":"Rudzi\u0144ska","year":"2010","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-39","first-page":"1807","volume-title":"Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment","author":"Xiao","year":"2016","journal-title":"Neurol Sci"},{"key":"key-10.4103\/0028-3886.226441-40","first-page":"1119","volume-title":"The difference of treatment results between botulinum toxin A split injection sites and botulinum toxin A non-split injection sites for hemifacial spasm","author":"Prutthipongsit","year":"2015","journal-title":"J Med Assoc Thail"},{"key":"key-10.4103\/0028-3886.226441-41","first-page":"119","volume-title":"Idiopathic cervical dystonia: Clinical characteristics","author":"Chan","year":"1991","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-42","first-page":"556","volume-title":"The double-chin posture: Posterior sagittal shift in cervical dystonia","author":"Pandey","year":"2016","journal-title":"Neurol India","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3886","issn-type":"print"},{"key":"key-10.4103\/0028-3886.226441-43","first-page":"524","volume-title":"Botulinum toxin treatment of spasmodic torticollis","author":"Anderson","year":"1992","journal-title":"J R Soc Med"},{"key":"key-10.4103\/0028-3886.226441-44","first-page":"749","volume-title":"Botulinum toxin therapy for cervical dystonia","author":"Walker","year":"2003","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"key-10.4103\/0028-3886.226441-45","first-page":"2519","volume-title":"Botulinum toxin as treatment for focal dystonia: A systematic review of the pharmaco-therapeutic and pharmaco-economic value","author":"Zoons","year":"2012","journal-title":"J Neurol"},{"key":"key-10.4103\/0028-3886.226441-46","first-page":"1325","volume-title":"Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia","author":"Chapman","year":"2007","journal-title":"Clin Ther"},{"key":"key-10.4103\/0028-3886.226441-47","first-page":"433","volume-title":"Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm","author":"Bihari","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"key-10.4103\/0028-3886.226441-48","doi-asserted-by":"crossref","unstructured":"Jinnah HA, Comella CL, Perlmutter J, Lungu C, Hallett M, Dystonia Coalition Investigators. Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy? Toxicon 2017 Sep 6; doi: 10.1016\/j.toxicon.2017.09.004.","DOI":"10.1016\/j.toxicon.2017.09.004"},{"key":"key-10.4103\/0028-3886.226441-49","doi-asserted-by":"crossref","unstructured":"Truong DD, Jost WH. Botulinum toxin: Clinical use. Parkinsonism Relat Disord. 2006;12:331-55.","DOI":"10.1016\/j.parkreldis.2006.06.002"},{"key":"key-10.4103\/0028-3886.226441-50","first-page":"162","volume-title":"Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment","author":"Pandey","year":"2017","journal-title":"J Neurol Sci"},{"key":"key-10.4103\/0028-3886.226441-51","first-page":"183","volume-title":"Botulinum toxin in movement disorders","author":"Papapetropoulos","year":"2007","journal-title":"Semin Neurol"},{"key":"key-10.4103\/0028-3886.226441-52","first-page":"186","volume-title":"Tardive and idiopathic oromandibular dystonia: A clinical comparison","author":"Tan","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0028-3886.226441-53","first-page":"1210","volume-title":"Hyoid muscle dystonia: A distinct focal dystonia syndrome","author":"Norby","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.4103\/0028-3886.226441-54","doi-asserted-by":"crossref","unstructured":"Jankovic J. An update on new and unique uses of botulinum toxin in movement disorders. Toxicon 2017 Sep 6;","DOI":"10.1016\/j.toxicon.2016.11.123"},{"key":"key-10.4103\/0028-3886.226441-55","first-page":"429","volume-title":"Primary focal lingual dystonia.Mov Disord","author":"Papapetropoulos","year":"2006","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-56","first-page":"358","volume-title":"Long-term effects of tetrabenazine in hyperkinetic movement disorders","author":"Jankovic","year":"1997","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-57","first-page":"93","volume-title":"Botulinum toxin injection for the treatment of oromandibular dystonia","author":"Blitzer","year":"1989","journal-title":"Ann OtolRhinolLaryngol"},{"key":"key-10.4103\/0028-3886.226441-58","first-page":"237","volume-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm","author":"Brin","year":"1987","journal-title":"MovDisord"},{"key":"key-10.4103\/0028-3886.226441-59","first-page":"1216","volume-title":"Treatment of oromandibular dystonia with botulinum toxin","author":"Hermanowicz","year":"1991","journal-title":"The Laryngoscope"},{"key":"key-10.4103\/0028-3886.226441-60","first-page":"633","volume-title":"Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.J Neurol Neurosurg Psychiatry","author":"Jankovic","year":"1990","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-61","first-page":"708","volume-title":"Oromandibular dystonia.Clinical forms, diagnosis and examples of therapy with botulinum toxin","author":"Laskawi","year":"2001","journal-title":"Laryngorhinootologie"},{"key":"key-10.4103\/0028-3886.226441-62","first-page":"720","volume-title":"Five-year experience in the treatment of focal movement disorders with low-dose Dysportbotulinum toxin","author":"Van","year":"1995","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.226441-63","first-page":"44","volume-title":"Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms","author":"Wan","year":"2005","journal-title":"Chin Med Sci J"},{"key":"key-10.4103\/0028-3886.226441-64","first-page":"211","volume-title":"Treating severe bruxism with botulinum toxin","author":"Tan","year":"2000","journal-title":"J Am Dent Assoc"},{"key":"key-10.4103\/0028-3886.226441-65","doi-asserted-by":"crossref","unstructured":"Jankovic J. An update on new and unique uses of botulinum toxin in movement disorders. Toxicon 2017 Sep 6; doi: 10.1016\/j.toxicon.2017.09.003.","DOI":"10.1016\/j.toxicon.2017.09.003"},{"key":"key-10.4103\/0028-3886.226441-66","first-page":"438","volume-title":"Lingual protrusion dystonia: Frequency, etiology and botulinum toxin therapy","author":"Esper","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.4103\/0028-3886.226441-67","doi-asserted-by":"crossref","unstructured":"Hennings JMH, Krause E, B\u00f6tzel K, Wetter TC. Successful treatment of tardive lingual dystonia with botulinum toxin: Case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1167-71.","DOI":"10.1016\/j.pnpbp.2007.09.010"},{"key":"key-10.4103\/0028-3886.226441-68","first-page":"41","volume-title":"Update on the use of botulinum toxin therapy for focal and task-specific dystonias","author":"Lungu","year":"2016","journal-title":"Semin Neurol"},{"key":"key-10.4103\/0028-3886.226441-69","first-page":"461","volume-title":"Writers' cramp-a focal dystonia","author":"Sheehy","year":"1982","journal-title":"Brain J Neurol"},{"key":"key-10.4103\/0028-3886.226441-70","first-page":"146","volume-title":"A practical approach to management of focal hand dystonia","author":"Pandey","year":"2015","journal-title":"Ann Indian Acad Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0972-2327","issn-type":"print"},{"key":"key-10.4103\/0028-3886.226441-71","first-page":"611","volume-title":"Botulinum neurotoxin treatment improves force regulation in writer's cramp","author":"Zeuner","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.4103\/0028-3886.226441-72","first-page":"355","volume-title":"Treatment of focal dystonias of the hand with botulinum toxin injections","author":"Cohen","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0028-3886.226441-73","first-page":"694","volume-title":"Botulinum toxin in the treatment of writer's cramp","author":"Behari","year":"1999","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/0028-3886.226441-74","first-page":"264","volume-title":"Botulinum toxin for writer's cramp: A randomised, placebo-controlled trial and 1-year follow-up","author":"Kruisdijk","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0028-3886.226441-75","first-page":"70","volume-title":"Long-term botulinum toxin treatment of focal hand dystonia","author":"Karp","year":"1994","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-76","first-page":"494","volume-title":"Prospective clinical study of writer's cramp","author":"Jedynak","year":"2001","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-77","first-page":"98","volume-title":"Writer's cramp","author":"Goldman","year":"2015","journal-title":"Toxicon"},{"key":"key-10.4103\/0028-3886.226441-78","first-page":"926","volume-title":"The focal dystonias: Current views and challenges for future research","author":"Jinnah","year":"2013","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-79","first-page":"172","volume-title":"Botulinum toxin in writer's cramp: Objective response evaluation in 31 patients","author":"Wissel","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0028-3886.226441-80","first-page":"433","volume-title":"Approach to a tremor patient","author":"Sharma","year":"2016","journal-title":"Ann Indian Acad Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0972-2327","issn-type":"print"},{"key":"key-10.4103\/0028-3886.226441-81","first-page":"62","volume-title":"Tremor","author":"Hsu","year":"2010","journal-title":"Acta Neurol Taiwan"},{"key":"key-10.4103\/0028-3886.226441-82","first-page":"1185","volume-title":"Botulinum toxin treatment of tremors","author":"Jankovic","year":"1991","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-83","first-page":"29","volume-title":"Botulinum toxin A in non-dystonic tremors","author":"Henderson","year":"1996","journal-title":"Eur Neurol"},{"key":"key-10.4103\/0028-3886.226441-84","doi-asserted-by":"crossref","unstructured":"Rostami R, Chow C, Richardson D, Jabbari B, Machado D. Botulinum toxin treatment of essential tremor - A customized approach. AAN-2016 2016; abstr. S27.002. Available from: URL: http:\/\/www.abstractsonline.com\/pp8\/#!\/4046\/ presentation\/6431. [Last accessed ob 2018 Feb 18].","DOI":"10.1212\/WNL.86.16_supplement.S27.002"},{"key":"key-10.4103\/0028-3886.226441-85","first-page":"348","volume-title":"Effective management of upper limb parkinsonian tremor by incobotulinumtoxina injections using sensor-based biomechanical patterns.Tremor Hyperkinetic Mov (N Y)","author":"Rahimi","year":"2015","journal-title":""},{"key":"key-10.4103\/0028-3886.226441-86","first-page":"601","volume-title":"Botulinum toxin A injections for the treatment of hand tremors","author":"Trosch","year":"1994","journal-title":"MovDisord"},{"key":"key-10.4103\/0028-3886.226441-87","first-page":"1359","volume-title":"Botulinum toxin in parkinson disease tremor: A randomized, double-blind, placebo-controlled study with a customized injection approach","author":"Mittal","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0028-3886.226441-88","unstructured":"Ludlow CL, Sedory SE, Fujita M, Naunton RF. Treatment of voice tremor with botulinum toxin injection. Neurology 1989;39(suppl 1) 353."},{"key":"key-10.4103\/0028-3886.226441-89","unstructured":"Brin MF, Blitzer A, Stewart C, Viswanath N, Beardsley A, Rosenfield D, et al. Laryngeal botulinum toxin (botox) injections in 431 patients with laryngeal movement disorders: Spasmodic dysphonia, adult stuttering and essential voice tremor. MovDisord 1992;7(suppl 1) 130."},{"key":"key-10.4103\/0028-3886.226441-90","doi-asserted-by":"crossref","unstructured":"Warrick P, Dromey C, Irish JC, Durkin L, Pakiam A, Lang A, Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: A crossover design study of unilateral versus bilateral injection. Laryngoscope2000;1101366-74.","DOI":"10.1097\/00005537-200008000-00028"},{"key":"key-10.4103\/0028-3886.226441-91","first-page":"410","volume-title":"The treatment of essential voice tremor with botulinum toxin A: A longitudinal case report","author":"Warrick","year":"2000","journal-title":"J Voice"},{"key":"key-10.4103\/0028-3886.226441-92","first-page":"1416","volume-title":"Botulinum Toxin Type A for Treating Voice Tremor","author":"Adler","year":"2004","journal-title":"Arch Neurol"},{"key":"key-10.4103\/0028-3886.226441-93","first-page":"94","volume-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders","author":"Hallett","year":"2013","journal-title":"Toxicon"},{"key":"key-10.4103\/0028-3886.226441-94","first-page":"637","volume-title":"Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease","author":"Sheffield","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"key-10.4103\/0028-3886.226441-95","first-page":"1818","volume-title":"Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-96","first-page":"511","volume-title":"An update on the use of botulinum toxin therapy in Parkinson's disease","author":"Mills","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key-10.4103\/0028-3886.226441-97","first-page":"610","volume-title":"\u201cApraxia of lid opening,\u201d a focal eyelid dystonia: Clinical study of 32 patients","author":"Krack","year":"1994","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"key-10.4103\/0028-3886.226441-98","first-page":"VII7","volume-title":"Dystonia in Parkinson's disease","author":"Tolosa","year":"2006","journal-title":"J Neurol"},{"key":"key-10.4103\/0028-3886.226441-99","first-page":"333","volume-title":"\u201cOff\u201d painful dystonia in Parkinson's disease treated with botulinum toxin","author":"Pacchetti","year":"1995","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-100","first-page":"1109","volume-title":"Drooling in Parkinson's Disease: A review","author":"Srivanitchapoom","year":"2014","journal-title":"Parkinsonism and Related Disorders"},{"key":"key-10.4103\/0028-3886.226441-101","first-page":"532","volume-title":"Botulinum toxin A for drooling in Parkinson's disease: A pilot study to compare submandibular to parotid gland injections","author":"Kalf","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.4103\/0028-3886.226441-102","first-page":"243","volume-title":"Is drooling secondary to a swallowing disorder in patients with Parkinson's disease?","author":"N\u00f3brega","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.4103\/0028-3886.226441-103","first-page":"93","volume-title":"Ultrasound-guided versus \u201cblind\u201d intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease","author":"Dogu","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"key":"key-10.4103\/0028-3886.226441-104","first-page":"313","volume-title":"Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease","author":"Guidubaldi","year":"2011","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-105","first-page":"1057","volume-title":"Treatment of drooling in Parkinson's disease with botulinum toxin","author":"Jost","year":"1999","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-106","first-page":"244","volume-title":"Botulinum toxin A as treatment for drooling saliva in PD","author":"Pal","year":"2000","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-107","first-page":"329","volume-title":"Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin","author":"Friedman","year":"2001","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.4103\/0028-3886.226441-108","first-page":"704","volume-title":"Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study","author":"Lagalla","year":"2006","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-109","first-page":"563","volume-title":"Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling","author":"Lagalla","year":"2009","journal-title":"J Neurol"},{"key":"key-10.4103\/0028-3886.226441-110","first-page":"1279","volume-title":"A randomized trial of botulinum toxin A for treatment of drooling","author":"Lipp","year":"2003","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-111","first-page":"685","volume-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinumtoxin type A in the treatment of drooling in parkinsonism","author":"Mancini","year":"2003","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-112","first-page":"1059","volume-title":"Botulinum toxin B reduces sialorrhea in parkinsonism","author":"Racette","year":"2003","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-113","first-page":"299","volume-title":"Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease","author":"Contarino","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.4103\/0028-3886.226441-114","first-page":"37","volume-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease","author":"Ondo","year":"2004","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-115","first-page":"219","volume-title":"Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial","author":"Chinnapongse","year":"2012","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-116","first-page":"313","volume-title":"Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease","author":"Guidubaldi","year":"2011","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-117","first-page":"1459","volume-title":"Sweating dysfunction in Parkinson's disease","author":"Swinn","year":"2003","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-118","first-page":"75","volume-title":"Camptocormia in Parkinson's disease: Definition, epidemiology, pathogenesis and treatment modalities","author":"Srivanitchapoom","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0028-3886.226441-119","first-page":"355","volume-title":"Camptocormia: Pathogenesis, classification, and response to therapy","author":"Azher","year":"2005","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-120","first-page":"889","volume-title":"Ultrasound-guided injection of the iliopsoas muscle with botulinum toxin in camptocormia","author":"Von","year":"2008","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-121","first-page":"316","volume-title":"Injection of the iliopsoas muscle with botulinum toxin in camptocormia","author":"Colosimo","year":"2009","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-122","first-page":"2027","volume-title":"Goal attainment after treatment of parkinsonian camptocormia with botulinum toxin","author":"Fietzek","year":"2009","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-123","first-page":"41","volume-title":"Long-term safety of therapeutic botulinum toxin A","author":"Naumann","year":"2008","journal-title":"Nervenarzt"},{"key":"key-10.4103\/0028-3886.226441-124","first-page":"354","volume-title":"Botulinum toxin type a and physiokinesiterapy in the treatment of Pisa syndrome","author":"Marvulli","year":"2017","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"key-10.4103\/0028-3886.226441-125","first-page":"139","volume-title":"Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease","author":"Santamato","year":"2010","journal-title":"J Neurol"},{"key":"key-10.4103\/0028-3886.226441-126","first-page":"871","volume-title":"Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena","author":"Bloem","year":"2004","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-127","first-page":"626","volume-title":"Botulinum toxin injections do not improve freezing of gait in Parkinson disease","author":"Wieler","year":"2005","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-128","first-page":"CR282","volume-title":"Botulinum toxin type B for gait freezing in Parkinson's disease","author":"Fernandez","year":"2004","journal-title":"Med Sci Monit"},{"key":"key-10.4103\/0028-3886.226441-129","first-page":"S482","volume-title":"Medical treatment of freezing of gait","author":"Giladi","year":"2008","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-130","first-page":"880","volume-title":"The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: A double blind placebo-controlled pilot study","author":"Gurevich","year":"2007","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-131","first-page":"250","volume-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","author":"Jankovic","year":"1996","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-132","first-page":"1523","volume-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","author":"Brin","year":"2001","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-133","first-page":"1722","volume-title":"Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease","author":"Schneider","year":"2006","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.226441-134","first-page":"1453","volume-title":"Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy","author":"Giannantoni","year":"2009","journal-title":"J Urol"},{"key":"key-10.4103\/0028-3886.226441-135","first-page":"960","volume-title":"Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder","author":"Giannantoni","year":"201;","journal-title":"J Urol"},{"key":"key-10.4103\/0028-3886.226441-136","first-page":"531","volume-title":"Use of botulinum toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease","author":"Kulaksizoglu","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.4103\/0028-3886.226441-137","first-page":"22","volume-title":"OnabotulinumtoxinA office treatment for neurogenic bladder incontinence in Parkinson's disease","author":"Anderson","year":"2014","journal-title":"Urology"},{"key":"key-10.4103\/0028-3886.226441-138","first-page":"997","volume-title":"Outlet type constipation in Parkinson's disease: Results of botulinum toxin treatment","author":"Cadeddu","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/0028-3886.226441-139","first-page":"2570","volume-title":"Experience with type A botulinum toxin for treatment of outlet-type constipation","author":"Maria","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/0028-3886.226441-140","first-page":"697","volume-title":"Botulinum toxin use in refractory pain and other symptoms in Parkinsonism","author":"Bruno","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"key-10.4103\/0028-3886.226441-141","first-page":"605","volume-title":"Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial","author":"Marras","year":"2001","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.226441-142","first-page":"1190","volume-title":"Botulinum toxin in the treatment of tics","author":"Kwak","year":"2000","journal-title":"Arch Neurol"},{"key":"key-10.4103\/0028-3886.226441-143","first-page":"420","volume-title":"Treatment of phonic tics inpatients with Tourette's syndrome using botulinum toxin type A","author":"Porta","year":"2004","journal-title":"Neurol Sci"},{"key":"key-10.4103\/0028-3886.226441-144","first-page":"443","volume-title":"Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck.Parkinsonism Relat Disord","author":"Aguirregomozcorta","year":"2008","journal-title":""}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:43:48Z","timestamp":1786715028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.226441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":144,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"alternative-id":["226441"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.226441","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}